Molecular events in neuroendocrine prostate cancer development

Wang, Yong; Wang, Yu; Ci, Xinpei; Choi, Stephen Y C; Crea, Francesco; Lin, Dong and Wang, Yuzhuo (2021). Molecular events in neuroendocrine prostate cancer development. Nature Reviews Urology, 18(10) pp. 581–596.

DOI: https://doi.org/10.1038/s41585-021-00490-0

Abstract

Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises de novo only rarely; the disease predominantly develops from adenocarcinoma in response to drug-induced androgen receptor signalling inhibition, although the mechanisms behind this transdifferentiation are a subject of debate. The survival of patients with NEPC is poor, and few effective treatment options are available. To improve clinical outcomes, understanding of the biology and molecular mechanisms regulating NEPC development is crucial. Various NEPC molecular drivers make temporal contributions during NEPC development, and despite the limited treatment options available, several novel targeted therapeutics are currently under research.

Viewing alternatives

Look up in Google Scholar

Metrics

Public Attention

Altmetrics from Altmetric

Number of Citations

Citations from Dimensions
No digital document available to download for this item

Item Actions

Export

About

CORE (COnnecting REpositories)

Recommendations